The lack of correlation between AGR2 and CA125 and AGR2 and midkine plasma concentrations in women with ovarian cancer may provide an opportunity to improve diagnostic efficiency by reducing the false negative rate and may be reflective of stage and/or tumor type- differential expression of AGR2 and CA125. This evidence concerns the gene AGR2 and ovarian cancer.